Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
Go back to Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.64 +0.14 (3.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $45.34 | |||
| Open | $4.41 | 52 Week Low | $15.92 | |||
| Day High | $4.71 | P/E | 1.99 | |||
| Day Low | $4.39 | EPS | $2.33 | |||
| Volume | 941,966 | |||||
